 |
인쇄하기
취소
|
LG, AstraZeneca to co-market Vimovo in Korea
Published: 2012-07-26 06:56:00
Updated: 2012-07-26 06:56:00
LG Life Sciences (LGLC) and AstraZeneca Korea (AZK) Tuesday announced that the two companies have signed an agreement to co-market AZK’s Vimovo tablets from next month in Korea.
Vimovo contains a combination of esomeprazole and naproxen. Naproxen is a nonsteroidal anti-inflammatory drug (NSAID). It works by reducing substances in the body that cause inflammation, pain, and fever. Esomeprazol...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.